March – Welcome from the Medical and Research Director

Prof. J. William McEvoy

NIPC Medical and Research Director, Chair of Executive Council

Welcome to the March NIPC e-bulletin. I am delighted to announce that we are now accepting applications for the NIPC Fellowship Programme 2024. Apply or nominate a colleague before the application deadline of 31st August.

The fellowship is intended to recognise individuals who have demonstrated outstanding commitment to the Institute and who have made highly significant contributions to the field of preventive medicine and cardiovascular health, either by virtue of their clinical leadership or track record in education, research and/or public policy development. If you are looking to advance your career and join a committed group of academic and clinical national and international leaders in cardiovascular disease prevention, then I strongly encourage you to consider applying.

NIPC have also just announced a brand-new course for 2024, “Advances in Heart Failure Prevention and Management: What Every Practitioner Should Know”. Heart Failure remains a leading cause of morbidity and mortality worldwide, posing significant challenges to patients, caregivers, and healthcare systems alike. Understanding its complexities, nuances and management strategies is paramount for all healthcare professionals involved in patient care. Of course many of the same risk factors that drive atherosclerotic cardiovascular disease also drive heart failure and in that sense heart failure is very often preventable. More details on this exciting announcement below.

We also invite GPs and Practice Nurses to register for our upcoming Diabetes Masterclass in the Croi Heart and Stroke Centre Galway on the 13th April. There are only a couple of places remaining, so I encourage you to act fast to avail of this invaluable opportunity to enhance your expertise and refine your skills in diabetes patient care.

On the research front I encourage you to consider reading our recent meta-analysis on Aspirin use in Primary CVD Prevention published in Circulation. We are also excited that the main report of our Interaspire study is now ready for submission to publication and hope to see it in print soon.

Many Thanks

Bill